# Insight Enterprises Inc: financial statements, quarterly

NSIT · Nasdaq · CIK 932696 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nsit.md) · [Financials](/companies/nsit/financials.md) · [Filings](/companies/nsit/filings.md) · [Insiders](/companies/nsit/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nsit/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,266](/filings/0001628280-24-044520.md) | [2,236 d](/filings/0000932696-26-000007.md) | [2,379](/filings/0001628280-25-021416.md) | [2,162](/filings/0001628280-25-036953.md) | [2,088](/filings/0000932696-25-000019.md) | [2,073 d](/filings/0000932696-26-000007.md) | [2,104](/filings/0000932696-26-000050.md) | [2,091](/filings/0000932696-26-000070.md) | [2,004](/filings/0000932696-25-000019.md) | [2,048 d](/filings/0000932696-26-000007.md) | [2,128](/filings/0000932696-26-000050.md) | [2,399](/filings/0000932696-26-000070.md) |
| Cost of revenue | $m | [1,857](/filings/0001628280-24-044520.md) | [1,800 d](/filings/0000932696-26-000007.md) | [1,939](/filings/0001628280-25-021416.md) | [1,708](/filings/0001628280-25-036953.md) | [1,656](/filings/0000932696-25-000019.md) | [1,633 d](/filings/0000932696-26-000007.md) | [1,697](/filings/0000932696-26-000050.md) | [1,649](/filings/0000932696-26-000070.md) | [1,570](/filings/0000932696-25-000019.md) | [1,570 d](/filings/0000932696-26-000007.md) | [1,666](/filings/0000932696-26-000050.md) | [1,878](/filings/0000932696-26-000070.md) |
| Gross profit | $m | [409](/filings/0001628280-24-044520.md) | [436 d](/filings/0000932696-26-000007.md) | [441](/filings/0001628280-25-021416.md) | [453](/filings/0001628280-25-036953.md) | [432](/filings/0000932696-25-000019.md) | [440 d](/filings/0000932696-26-000007.md) | [406](/filings/0000932696-26-000050.md) | [442](/filings/0000932696-26-000070.md) | [434](/filings/0000932696-25-000019.md) | [478 d](/filings/0000932696-26-000007.md) | [462](/filings/0000932696-26-000050.md) | [522](/filings/0000932696-26-000070.md) |
| Selling, general and administrative | $m | [310](/filings/0001628280-24-044520.md) | [298 d](/filings/0000932696-26-000007.md) | [337](/filings/0001628280-25-021416.md) | [317](/filings/0001628280-25-036953.md) | [330](/filings/0000932696-25-000019.md) | [358 d](/filings/0000932696-26-000007.md) | [339](/filings/0000932696-26-000050.md) | [352](/filings/0000932696-26-000070.md) | [333](/filings/0000932696-25-000019.md) | [361 d](/filings/0000932696-26-000007.md) | [384](/filings/0000932696-26-000050.md) | [385](/filings/0000932696-26-000070.md) |
| Operating income | $m | [91.9](/filings/0001628280-24-044520.md) | [132 d](/filings/0000932696-26-000007.md) | [100.0](/filings/0001628280-25-021416.md) | [131](/filings/0001628280-25-036953.md) | [92.9](/filings/0000932696-25-000019.md) | [64.7 d](/filings/0000932696-26-000007.md) | [60.1](/filings/0000932696-26-000050.md) | [86.5](/filings/0000932696-26-000070.md) | [93.1](/filings/0000932696-25-000019.md) | [95.2 d](/filings/0000932696-26-000007.md) | [71.7](/filings/0000932696-26-000050.md) | [131](/filings/0000932696-26-000070.md) |
| Interest expense | $m | [12.0](/filings/0001628280-23-036274.md) | [9.4 d](/filings/0001628280-24-006391.md) | [12.6](/filings/0001628280-24-020070.md) | [14.2](/filings/0001628280-25-036953.md) | [16.6](/filings/0000932696-25-000019.md) | [14.7 d](/filings/0000932696-26-000007.md) | [15.6](/filings/0000932696-26-000050.md) | [22.4](/filings/0000932696-26-000070.md) | [23.3](/filings/0000932696-25-000019.md) | [23.6 d](/filings/0000932696-26-000007.md) | [23.6](/filings/0000932696-26-000050.md) | [24.4](/filings/0000932696-26-000070.md) |
| Income tax | $m | [19.8](/filings/0001628280-24-044520.md) | [31.6 d](/filings/0000932696-26-000007.md) | [21.2](/filings/0001628280-25-021416.md) | [29.9](/filings/0001628280-25-036953.md) | [16.9](/filings/0000932696-25-000019.md) | [15.2 d](/filings/0000932696-26-000007.md) | [11.5](/filings/0000932696-26-000050.md) | [17.2](/filings/0000932696-26-000070.md) | [19.7](/filings/0000932696-25-000019.md) | [20.0 d](/filings/0000932696-26-000007.md) | [19.5](/filings/0000932696-26-000050.md) | [28.7](/filings/0000932696-26-000070.md) |
| Net income | $m | [60.2](/filings/0001628280-24-044520.md) | [90.6 d](/filings/0000932696-26-000007.md) | [67.0](/filings/0001628280-25-021416.md) | [87.4](/filings/0001628280-25-036953.md) | [58.2](/filings/0000932696-25-000019.md) | [37.0 d](/filings/0000932696-26-000007.md) | [7.5](/filings/0000932696-26-000050.md) | [46.9](/filings/0000932696-26-000070.md) | [50.9](/filings/0000932696-25-000019.md) | [52.0 d](/filings/0000932696-26-000007.md) | [30.0](/filings/0000932696-26-000050.md) | [77.6](/filings/0000932696-26-000070.md) |
| Diluted EPS | $ per share | [1.62](/filings/0001628280-24-044520.md) | not reported | [1.74](/filings/0001628280-25-021416.md) | [2.27](/filings/0001628280-25-036953.md) | [1.52](/filings/0000932696-25-000019.md) | not reported | [0.22](/filings/0000932696-26-000050.md) | [1.46](/filings/0000932696-26-000070.md) | [1.62](/filings/0000932696-25-000019.md) | not reported | [0.97](/filings/0000932696-26-000050.md) | [2.57](/filings/0000932696-26-000070.md) |
| Basic EPS | $ per share | [1.85](/filings/0001628280-24-044520.md) | not reported | [2.06](/filings/0001628280-25-021416.md) | [2.69](/filings/0001628280-25-036953.md) | [1.81](/filings/0000932696-25-000019.md) | not reported | [0.24](/filings/0000932696-26-000050.md) | [1.48](/filings/0000932696-26-000070.md) | [1.62](/filings/0000932696-25-000019.md) | not reported | [0.97](/filings/0000932696-26-000050.md) | [2.58](/filings/0000932696-26-000070.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001628280-23-036274.md) | [0.3](/filings/0001628280-25-005817.md) | [0.4](/filings/0001628280-24-020070.md) | [0.3](/filings/0001628280-24-034041.md) | [0.3](/filings/0001628280-24-044520.md) | [0.3](/filings/0000932696-26-000007.md) | [0.3](/filings/0001628280-25-021416.md) | [0.3](/filings/0001628280-25-036953.md) | [0.5](/filings/0000932696-25-000019.md) | [0.4](/filings/0000932696-26-000070.md) | [0.4](/filings/0000932696-26-000050.md) | [0.4](/filings/0000932696-26-000070.md) |
| Current assets | $bn | [3.7](/filings/0001628280-23-036274.md) | [4.3](/filings/0001628280-25-005817.md) | [4.4](/filings/0001628280-24-020070.md) | [4.9](/filings/0001628280-24-034041.md) | [4.7](/filings/0001628280-24-044520.md) | [4.8](/filings/0000932696-26-000007.md) | [5.4](/filings/0001628280-25-021416.md) | [6.3](/filings/0001628280-25-036953.md) | [6.5](/filings/0000932696-25-000019.md) | [6.4](/filings/0000932696-26-000070.md) | [7.5](/filings/0000932696-26-000050.md) | [8.8](/filings/0000932696-26-000070.md) |
| Total assets | $bn | [5.1](/filings/0001628280-23-036274.md) | [6.3](/filings/0001628280-25-005817.md) | [6.6](/filings/0001628280-24-020070.md) | [7.4](/filings/0001628280-24-034041.md) | [7.3](/filings/0001628280-24-044520.md) | [7.4](/filings/0000932696-26-000007.md) | [7.9](/filings/0001628280-25-021416.md) | [8.7](/filings/0001628280-25-036953.md) | [8.9](/filings/0000932696-25-000019.md) | [9.1](/filings/0000932696-26-000070.md) | [10.1](/filings/0000932696-26-000050.md) | [11.4](/filings/0000932696-26-000070.md) |
| Current liabilities | $bn | [2.7](/filings/0001628280-23-036274.md) | [3.4](/filings/0001628280-25-005817.md) | [3.5](/filings/0001628280-24-020070.md) | [4.0](/filings/0001628280-24-034041.md) | [3.7](/filings/0001628280-24-044520.md) | [4.1](/filings/0000932696-26-000007.md) | [4.4](/filings/0001628280-25-021416.md) | [4.9](/filings/0001628280-25-036953.md) | [5.0](/filings/0000932696-25-000019.md) | [5.1](/filings/0000932696-26-000070.md) | [6.1](/filings/0000932696-26-000050.md) | [7.4](/filings/0000932696-26-000070.md) |
| Total liabilities | $bn | [3.5](/filings/0001628280-23-036274.md) | [4.6](/filings/0001628280-25-005817.md) | [4.8](/filings/0001628280-24-020070.md) | [5.5](/filings/0001628280-24-034041.md) | [5.5](/filings/0001628280-24-044520.md) | [5.7](/filings/0000932696-26-000007.md) | [6.3](/filings/0001628280-25-021416.md) | [7.1](/filings/0001628280-25-036953.md) | [7.3](/filings/0000932696-25-000019.md) | [7.4](/filings/0000932696-26-000070.md) | [8.5](/filings/0000932696-26-000050.md) | [9.8](/filings/0000932696-26-000070.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.6](/filings/0001628280-24-044520.md) | [1.7](/filings/0000932696-26-000007.md) | [1.8](/filings/0001628280-25-036953.md) | [1.8](/filings/0000932696-25-000019.md) | [1.8](/filings/0000932696-25-000019.md) | [1.8](/filings/0000932696-26-000070.md) | [1.6](/filings/0000932696-26-000070.md) | [1.6](/filings/0000932696-26-000070.md) | [1.6](/filings/0000932696-25-000019.md) | [1.6](/filings/0000932696-26-000070.md) | [1.6](/filings/0000932696-26-000070.md) | [1.6](/filings/0000932696-26-000070.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [226 d](/filings/0001628280-24-044520.md) | [206 d](/filings/0000932696-26-000007.md) | [247](/filings/0001628280-25-021416.md) | [45.8 d](/filings/0001628280-25-036953.md) | [125 d](/filings/0000932696-25-000019.md) | [215 d](/filings/0000932696-26-000007.md) | [78.1](/filings/0000932696-26-000050.md) | [(177) d](/filings/0000932696-26-000070.md) | [249 d](/filings/0000932696-25-000019.md) | [154 d](/filings/0000932696-26-000007.md) | [32.4](/filings/0000932696-26-000050.md) | [(12.2) d](/filings/0000932696-26-000070.md) |
| Capital expenditure | $m | [15.9 d](/filings/0001628280-24-044520.md) | [10.2 d](/filings/0000932696-26-000007.md) | [6.5](/filings/0001628280-25-021416.md) | [12.2 d](/filings/0001628280-25-036953.md) | [13.7 d](/filings/0000932696-25-000019.md) | [14.4 d](/filings/0000932696-26-000007.md) | [7.1](/filings/0000932696-26-000050.md) | [4.8 d](/filings/0000932696-26-000070.md) | [5.6 d](/filings/0000932696-25-000019.md) | [7.0 d](/filings/0000932696-26-000007.md) | [6.0](/filings/0000932696-26-000050.md) | [7.9 d](/filings/0000932696-26-000070.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-044520.md) | [0.0 d](/filings/0000932696-26-000007.md) | [35.0](/filings/0001628280-25-021416.md) | [0.0 d](/filings/0001628280-25-036953.md) | [165 d](/filings/0000932696-25-000019.md) | [0.0 d](/filings/0000932696-26-000007.md) | [0.0](/filings/0000932696-26-000050.md) | [76.1 d](/filings/0000932696-26-000070.md) | [75.0 d](/filings/0000932696-25-000019.md) | [0.0 d](/filings/0000932696-26-000007.md) | [75.0](/filings/0000932696-26-000050.md) | [75.0 d](/filings/0000932696-26-000070.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [36.3](/filings/0001628280-23-036274.md) | [37.2](/filings/0001628280-24-020070.md) | [37.0](/filings/0001628280-24-034041.md) | [37.2](/filings/0001628280-24-044520.md) | [38.4](/filings/0001628280-25-021416.md) | [38.6](/filings/0001628280-25-036953.md) | [38.3](/filings/0000932696-25-000019.md) | [34.7](/filings/0000932696-26-000050.md) | [32.1](/filings/0000932696-26-000070.md) | [31.5](/filings/0000932696-25-000019.md) | [30.9](/filings/0000932696-26-000050.md) | [30.2](/filings/0000932696-26-000070.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,348,850 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000932696-26-000070.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.